The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Aptevo Therapeutics Inc’s current trading price is -99.50% away from its 52-week high, while its distance from the 52-week low is -6.83%. The stock’s price range for this period has been between $2.05 and $381.10 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 0.54 million for the day, a number notably lower than the average daily volume of 2.29 million over the last three months.
Aptevo Therapeutics Inc (APVO) stock is currently valued at $1.91. During the last session, the stock experienced a remarkable rise, reaching $420.0 after opening at $1.91. The stock briefly dropped to $420.0 before ultimately closing at $2.06.
Aptevo Therapeutics Inc experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $381.10 on 10/22/24, while the lowest price for the same period was registered at $2.05 on 08/13/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Aptevo Therapeutics Inc (APVO) has experienced a quarterly decline of -71.91% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 6.28M and boasts a workforce of 42 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 9.50, with a change in price of -47.49. Similarly, Aptevo Therapeutics Inc recorded 1,543,412 in trading volume during the last 100 days, posting a change of -96.13%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for APVO stands at 0.65. Similarly, the long-term debt-to-equity ratio is also 0.65.
APVO Stock Stochastic Average
Aptevo Therapeutics Inc’s raw stochastic average for the past 50 days is presently 0.44%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 3.47%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 2.83% and 5.33%, respectively.
APVO Stock Price Performance Analysis
The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Until today this year the stock’s price performance recorded a decrease of -99.31%. However, over the last six months, the performance has been stronger by -97.43%. The price of APVO decreased -34.59% over the last 30 days. And in the last five days, it has fallen by -11.98%.
